ライフサイエンスコーパス: seropositive

1 bercular treatment and most of whom were HIV seropositive.

2 Mothers of 157 infants (83.5%) were CMV-seropositive.

3 n starting ART aged older than 24 weeks were seropositive.

4 uded, 209 (68%) of whom were cytomegalovirus seropositive.

5 One patient was dual seropositive.

6 Out of the 250 cases, 155 (62%) were seropositive.

7 All patients were Epstein-Barr virus IgG seropositive.

8 patients were female, and 42 (30%) were HIV seropositive.

9 serologically screened individuals, 26% were seropositive.

10 4 years (IQR: 27-44), and 130 (28%) were HIV seropositive.

11 12 years of chronological age for those CMV seropositive.

12 Two American robins were also seropositive.

13 were HCV seropositive; 26 (3.1%) were HTLV-1-seropositive.

14 of 217 of 839 participants (25.9%) were HCV seropositive; 26 (3.1%) were HTLV-1-seropositive.

15 2%; 95% confidence interval, 0.7%-4.3%) were seropositive, 3 with documented travel and 1 who had an

16 stem (PNS) manifestations, 39% were LGI1-IgG seropositive (7% had solely neuropathy or pain).

17 2.7 to 96.1) in the subcutaneous group, were seropositive, a difference of -9.2 percentage points (95

18 though individuals in all professions tested seropositive, abattoir workers (10 of 97; 10.3%) were si

19 8% in HIV-seronegative adults and 71% in HIV-seropositive adults (odds ratio, 6.2; 95% confidence int

20 frequency and quantity are high among HSV-2-seropositive adults in sub-Saharan Africa, including per

21 es plasma interleukin 6 (IL-6) levels in CMV-seropositive adults who are critically ill.

22 Among CMV-seropositive adults with critical illness due to sepsis

23 ys (November 10, 2016) that included 160 CMV-seropositive adults with either sepsis or trauma and res

24 t pre-existing neutralizing responses in RSV seropositive adults.

25 ge, resulting in around 98% of infants being seropositive against type 2.

26 We prospectively monitored 63 CMV-seropositive allo-HCT recipients with a CMV-specific enz

27 IgG-seronegative patients who receive an IgG-seropositive allograft do not develop CMV infection desp

28 dies investigating the infectiousness of HIV-seropositive and -seronegative index cases have been per

29 We assessed the infectiousness of HIV-seropositive and -seronegative patients with tuberculosi

30 717 of 974 (73.6%) household contacts of HIV-seropositive and -seronegative tuberculosis cases (relat

31 npregnant asymptomatic adults who were HSV-2 seropositive and 2 in HSV-2-serodiscordant couples.

32 A total of 49 542 HSCT patients, 29 349 seropositive and 20 193 seronegative, were identified fr

33 oid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors.

34 d for diagnosing dengue fever, 93 cases were seropositive and 67 cases were seronegative.

35 novel susceptibility factors for PTLD in EBV-seropositive and EBV-seronegative individuals, respectiv

36 ean follow-up of 8.2 years, we observed (HCV seropositive and HCV seronegative, respectively) 107 and

37 ng and immunohistochemical analyses of HIV-1 seropositive and HIV-1 encephalitic human brain tissues

38 the frequency of genital HSV shedding in HIV-seropositive and HIV-seronegative men and women in Ugand

39 an immunodeficiency virus (HIV)-infected HCV-seropositive and incidence density-matched HCV-seronegat

40 rum and longitudinal outcome in 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.

41 ngly, in both studies, immunization of HSV-1-seropositive animals had little effect on recurrent vagi

42 e against genital disease in naive and HSV-1-seropositive animals.

43 A total of 2,139 HBsAg-seropositive, anti-HCV-seronegative, and treatment-naive

44 (+) T cells from HLA-A*02:01 positive, HSV-1 seropositive ASYMP and symptomatic (SYMP) individuals (w

45 ially studied HLA-A*02:01-positive and HSV-1-seropositive ASYMP individuals, the most frequent, robus

46 onors who were seropositive in 2005 remained seropositive at 5 years and maintained neutralizing anti

47 tion in 64% of all participants; among those seropositive at age 15-16 years, 84% were predicted to r

48 ldren in the subcutaneous group [94.7%] were seropositive at day 91, a difference of -9.3 percentage

49 Seven of 12 individuals were JCV antibody seropositive based on absorbance units.

50 Most subjects were seropositive before MMR3 receipt, and very few had a sec

51 d 3 HEV reinfections among patients who were seropositive before transplantation through detection of

52 specificity of antibody responses in 370 WNV-seropositive blood donors.

53 Smokers were more likely to be HPyV9-seropositive but MCV-seronegative, and HPyV7 seropositiv

54 ents carrying KIR2DS4*00101 alleles were CMV seropositive, but not control individuals, and exhibited

55 ects with CSF-serum pairs, 26 were NMDAR1 AB seropositive, but only 1 was CSF positive.

56 is of neuromyelitis optica for 2 patients as seropositive by both ELISA and CBA.

57 the head and neck cancer GWAS limited to HPV-seropositive cases and an independent cervical cancer GW

58 The age range of the seropositive cases was 1 to 78 years with the mean age o

59 Seropositive cases were tested additionally by fluoresce

60 We here assess DS-Cav1 F immunogenicity in seropositive cattle pre-exposed to bovine RSV, a virus c

61 V-serostatus (11 [48%] of 23 symptomatic HIV-seropositive child contacts vs two [7%] of 31 asymptomat

62 contacts vs two [7%] of 31 asymptomatic HIV-seropositive child contacts) or to only culture-confirme

63 in 250 classic (non-AIDS) KS cases, 280 KSHV-seropositive controls, and 576 KSHV-seronegative control

64 Most (78%) had seropositive convalescent specimens.

65 7 of 12 (58.3%) seronegative recipients of a seropositive donor (positive donor/negative recipient [D

66 cially in patients receiving an organ from a seropositive donor (SHR, 1.92 [95% CI, 1.30-2.85]; P = .

67 ted that HHV-8 was likely transmitted by the seropositive donor at the time of transplantation.

68 ve patient, our data support selecting a CMV-seropositive donor if the patient receives a myeloablati

69 chimerism status in a subset of R+/D- and R+/seropositive donor patients.

70 8-DNA was detected in 6.8% and 2.9% of HHV8-seropositive donor samples by in-house nested PCR and qu

71 , were cytomegalovirus seropositive or had a seropositive donor, and underwent weekly plasma cytomega

72 plant, 3 (25%) of 12 HHV8-mismatch patients (seropositive donor/seronegative recipient) developed a p

73 eronegative recipients receiving organs from seropositive donors (D+R-) and 104 seropositive recipien

74 ope is robustly recognized by CD4 T cells of seropositive donors across diverse HLA haplotypes.

75 Seropositive donors also had no influence on relapse-fre

76 e analysis, recipients receiving grafts from seropositive donors had a higher risk of chronic GVHD th

77 Patients receiving grafts from EBV-seropositive donors had the same overall survival as pat

78 In seronegative patients with seropositive donors, the HR for chronic GVHD was 1.30 (9

79 In seropositive patients with seropositive donors, the HR was 1.24 (95% CI, 1.07 to 1.

80 D4(+) TH1 proliferation response only in CMV-seropositive donors.

81 31 of 34 renal transplant biopsies from HCMV-seropositive donors.

82 Thirty percent of men (486) were seropositive for >/=1 HPV type, and 25 men developed inc

83 PML risk increases in individuals seropositive for anti-John Cunningham virus (JC) antibod

84 that approximately 31.4% of 433 horses were seropositive for antibodies (Abs) against NPHV and appro

85 g was positive for Eurasian H5 viral RNA and seropositive for antibodies reactive to the Eurasian H5

86 a patient with NMOSD whose test results were seropositive for aquaporin-4 IgG and who had a hepatic m

87 who had ataxia, were 18 years or older, were seropositive for at least 1 neural autoantibody, had rec

88 in seroprevalence, at least 9% of males were seropositive for at least 1 of the 4 HPV types.

89 ttransplant: 78 (57%) of F-->M patients were seropositive for at least 1 of the 6 HY-Abs, and 3-month

90 All participants were seropositive for at least 1 PyV, with seroprevalences ra

91 9 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB

92 her in vaccinated than unvaccinated subjects seropositive for both antibody to hepatitis B surface an

93 mated that 302 of 469 (64.4%) red foxes were seropositive for canine adenovirus (CAV) by ELISA.

94 ong predictor of CNS involvement in patients seropositive for CASPR2-IgG or LGI1-IgG.

95 G6 IgA seropositive individuals (59.1%) were seropositive for celiac disease-related alleles compared

96 Patients seropositive for cytomegalovirus (CMV) and undergoing al

97 ls are expanded in patients with AAV who are seropositive for cytomegalovirus (CMV), and are associat

98 nts with APECED lacked Paneth cells and were seropositive for defensin-specific autoantibodies; the p

99 There were decreases in proportion seropositive for every HPV type across all age groups, m

100 Two of 207 (1%) participants were seropositive for H5 and 4 of 207 (2%) for H7 in 2011, co

101 Among state veterinarians, 4 of 37(11%) were seropositive for H7 and 1 of 37 (2.7%) for H5.

102 e found in healthy ASYMP individuals who are seropositive for HSV-1 but never had any recurrent herpe

103 entive interventions in asymptomatic persons seropositive for HSV-2.

104 Among 2 047 740 first-time donors, 104 were seropositive for HTLV-1 (prevalence, 5.1 cases/per 100 0

105 idence interval [CI], 4.1-6.1), and 300 were seropositive for HTLV-2 (prevalence, 14.7 cases/per 100

106 presentation, 16% of patients with BMD were seropositive for IgG and/or IgM antibody to B. miyamotoi

107 ter vaccination, all vaccinated rabbits were seropositive for IgG to F. tularensis lipopolysaccharide

108 d distribution; proportions of US population seropositive for measles and rubella; and measles-mumps-

109 Equally high proportions of the samples were seropositive for measles virus, mumps virus, or rubella

110 22) individuals older than 15 years might be seropositive for MERS-CoV in Saudi Arabia.

111 Eighty-one patients were seropositive for NNC antibodies (most commonly PCA-1 [an

112 We determined the proportion of females seropositive for PV antibody by 5-year age strata, and a

113 initial TNF inhibitor treatment in patients seropositive for rheumatoid arthritis and naive to treat

114 While 8 of the primatologists tested were seropositive for SFV from a NWM, the spider monkey, none

115 Two groups of children born to mothers seropositive for T. cruzi were compared: 101 had congeni

116 The patients seropositive for TG6 showed a classic picture of ALS, si

117 ak strain, 86.9% (95% CI, 75.8 to 94.2) were seropositive for the 44/76-SL strain, for which there wa

118 f these vaccinees (95% CI, 94.1 to 100) were seropositive for the 5/99 strain and had a higher geomet

119 Seventy-one percent were seropositive for the JC polyomavirus.

120 18 of 25 participants with sIBM (72%) were seropositive for the NT5c1A antibody.

121 nated and unvaccinated participants who were seropositive for the outbreak strain and for one closely

122 confidence interval [CI], 61.8 to 70.3) were seropositive for the outbreak strain, although the geome

123 e found significantly more frequently in the seropositive group.

124 e efficacy in herpes simplex virus 1 (HSV-1)-seropositive guinea pigs immunized and subsequently chal

125 with Iscomatrix and alum to HSV-1-naive or -seropositive guinea pigs.

126 onegative (HCMV(-)) individuals than in HCMV-seropositive (HCMV(+)) individuals.

127 y blood-derived T cells of 5 of 17 HSV-1/VZV-seropositive healthy adults but not in cord blood donors

128 t women, as well as CMV-seronegative and CMV-seropositive healthy adults, were included as controls.

129 le in the "natural" protection seen in HSV-1-seropositive healthy asymptomatic (ASYMP) individuals (w

130 y a role in the "natural" protection seen in seropositive healthy asymptomatic (ASYMP) individuals (w

131 as well as 26 HCMV-seronegative and 39 HCMV-seropositive healthy controls.

132 ccine in baseline Ad26-seronegative and Ad26-seropositive healthy volunteers.

133 dred fifty-six hepatitis B e antigen (HBeAg)-seropositive, hepatitis B surface antigen (HBsAg) carrie

134 nonuclear cell samples from 108 CMV- and EBV-seropositive HIV-infected men who have sex with men, who

135 are described in a prospective study of HCV-seropositive HIV-infected patients at Cipto Mangunkusomo

136 ose uptake by monocyte subpopulations in HIV-seropositive (HIV(+)) treatment-naive individuals (n = 1

137 d genital secretions were collected from HIV-seropositive (HIV+) Kenyan female sex workers (FSWs) (n

138 mononuclear cell (PBMC) samples from 107 CMV-seropositive, HIV-infected men who have sex with men, wh

139 Treating everyone within seropositive households (63% population) would target 77

140 cells of 'humanized' HLA transgenic mice and seropositive human donors.

141 Seropositive human sera also neutralize Hendra virus and

142 ng-running community-recruited cohort of HIV-seropositive illicit drug users during a community-wide

143 A total of 115 cytomegalovirus seropositive, immunocompetent adults with critical illne

144 All donors who were seropositive in 2005 remained seropositive at 5 years an

145 ven in susceptible individuals that are ACPA-seropositive in human arthritis.

146 sis contact investigation should include HIV-seropositive index cases in high disease burden settings

147 sis cases modified the infectiousness of HIV-seropositive indexes.

148 e for P. jirovecii; however, most adults are seropositive, indicating natural immune priming to this

149 ecific HLA antigen alleles; 13 of 22 TG6 IgA seropositive individuals (59.1%) were seropositive for c

150 Here, whole blood of healthy seropositive individuals (n = 75), living in N.

151 eas HLA-B8 was a risk factor for PTLD in EBV-seropositive individuals (OR = 3.29, 95% CI = 1.52-7.09)

152 amma, perforin, and CD107a expression) in 76 seropositive individuals aged 70 years or older.

153 responses seen with age but suggest that CMV-seropositive individuals differ in their natural exposur

154 Across age groups, cytomegalovirus seropositive individuals displayed immunotypes character

155 responses were lower in P. falciparum lysate-seropositive individuals than in seronegative individual

156 The mean age of seropositive individuals was significantly younger than

157 te controllers (ECs) are a rare group of HIV seropositive individuals who are able to control viral r

158 pandemic health problem, and the majority of seropositive individuals will eventually progress to AID

159 Of 148 seropositive individuals, 40 fulfilled inclusion criteri

160 frequencies in human cytomegalovirus (HCMV)-seropositive individuals, and these have been shown to h

161 In 100 HCMV-seropositive individuals, the GM3/17 polymorphism, serum

162 Among HCV-seropositive individuals, treated participants without S

163 to achieve a therapeutic effect in other HIV-seropositive individuals.

164 antigen targeted by CD8(+) T cells from HSV-seropositive individuals.

165 major Ag targeted by CD8(+) T cells from HSV-seropositive individuals.

166 of coronary heart disease in cytomegalovirus-seropositive individuals.

167 tners in stable or casual relationships with seropositive individuals.

168 Previously, we examined IgGs from 10 HSV-seropositive individuals; all neutralized virus and were

169 roup heterogeneity, suggesting a subgroup of seropositive-like cases within seronegative cases (PBUHM

170 CMV-seropositive lung transplantation recipients were includ

171 RhCMV-seropositive macaques, which shed RhCMV in saliva, were

172 fection and the first malaria episode (PfRH5-seropositive median: 71 days, PfRH5-seronegative median:

173 ions were observed for HPV 16 among baseline-seropositive men [adjusted HR, 1.37; 95% confidence inte

174 V 18 infection was significantly lower among seropositive men in the unadjusted model (HR, 0.22; 95%

175 titers of protective antibodies from highly seropositive mothers have not been studied in detail.

176 ific T-cell responses in breast milk of HCMV-seropositive mothers is not well defined.

177 We enrolled 43 JCV-seropositive MS patients, including 32 on natalizumab mo

178 mune response is highly prevalent in all JCV-seropositive MS patients, regardless of treatment.

179 te race/ethnicity with highly active AQP4-ab-seropositive NMO (n = 6) and NMO spectrum disorder (n =

180 splants in which donor or recipient were CMV seropositive (non-D-/R-), compared with D- transplant or

181 A high proportion of seropositive OLM cases had uveitis (34.19%) followed by

182 The most frequent clinical presentation of seropositive OLM cases were unilateral reduced vision an

183 tigen using matched T cells and MCs from CMV-seropositive or CMV-seronegative donors, and for antigen

184 2007, and Feb 28, 2013, were cytomegalovirus seropositive or had a seropositive donor, and underwent

185 men on antiretroviral therapy who were HSV-2 seropositive or seronegative and HIV-uninfected controls

186 influenced by whether the subjects were CMV seropositive or seronegative.

187 Females have higher odds of being seropositive (OR=2.30).

188 dren with PHIV and 97% of PHEU children were seropositive (P < .001).

189 We included 2503 HCV-seropositive participants (540 with spontaneous HCV clea

190 A undetectability were analyzed in 431 HBeAg-seropositive participants and 1,708 HBeAg-seronegative p

191 PBMCs isolated from healthy CMV/EBV seropositive participants before (PRE) and immediately a

192 re included in the analytic sample (2278 HIV-seropositive participants contributed 20 477 visits and

193 Compared with HCV-negative controls, HCV-seropositive participants had an increased risk of liver

194 eview and meta-analysis was conducted of HIV-seropositive participants receiving ART compared with no

195 % to 27.7% (P < .001), and 48.4% of unlinked seropositive participants were linked to HIV care throug

196 Seropositive participants were more likely to require as

197 Facial weakness occurred in 50% of seropositive participants while it was only seen in 14%

198 tis D virus RNA among anti-hepatitis D virus seropositive participants.

199 fication products were obtained from 118 HCV-seropositive participants; subtypes 4k (in 47 participan

200 Of 132 women with HSV2-seropositive partners, seroconversion was 36.4 per 100 p

201 For a CMV-seropositive patient, our data support selecting a CMV-s

202 was found in 44% of LGI1-IgG/CASPR2-IgG dual seropositive patients (one-third thymoma).

203 l therapy in immunocompetent cytomegalovirus seropositive patients admitted to the ICU with acute res

204 (null) cells were found predominantly in CMV-seropositive patients and expanded in the posttransplant

205 es amplified from HDV seroconverters and HDV-seropositive patients at baseline.

206 o the major CMV pp65 and IE-1 antigens in 15 seropositive patients at intermediate risk of CMV infect

207 cing lesions from 284 aquaporin-4 (AQP4)-IgG seropositive patients at Mayo Clinic from 1996 to 2014.

208 Cytomegalovirus-seropositive patients demonstrated a greater fall in the

209 ailable from 96 of 118 consecutive PCA-2-IgG-seropositive patients identified during 1993-2016.

210 trospective review of the medical records of seropositive patients identified in the Mayo Clinic Neur

211 r, the importance of donor serostatus in CMV-seropositive patients is controversial.

212 Seropositive patients receiving grafts from seropositive

213 ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous co

214 utoantibodies against glutamatergic NMDAR in seropositive patients who cannot be clinically identifie

215 Among 70 seropositive patients whose medical records were availab

216 We assessed whether CD4+CD28- T cells in CMV seropositive patients with AAV are associated with arter

217 n strategy targeting an unselected cohort of seropositive patients with acute respiratory distress sy

218 gG serostatus was longitudinally assessed in seropositive patients with available serum samples and a

219 Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp

220 Seropositive patients with seronegative donors did not h

221 In seropositive patients with seropositive donors, the HR w

222 In the first study, 889 untreated anti-HCV-seropositive patients without HCC symptoms were followed

223 possible cause of neurodegeneration in HIV-1-seropositive patients, which engages the ability of p17

224 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.

225 elerated immunosenescence in cytomegalovirus-seropositive patients.

226 depleted for >/=3 months in cytomegalovirus-seropositive patients.

227 celerate immunosenescence in cytomegalovirus-seropositive patients.

228 rus-specific CD8(+) cells in cytomegalovirus-seropositive patients.

229 red as index, may further define PML risk in seropositive patients.

230 aphic factors and clinical manifestations of seropositive patients.

231 tion, but EBV DNAemia detection in low-risk (seropositive) patients has poor specificity as a biomark

232 NS3-1073 and NS5-2594 were expanded from HCV-seropositive persons by peptide stimulation in vitro or

233 Cytomegalovirus-seropositive persons commonly lack detectable levels of

234 e same regardless of the proportion of HCVAb-seropositive persons in the cohort being tested.

235 rom each region in 28 immunocompetent, HSV-2-seropositive persons.

236 IBV was detected in 3 nasal swabs from PRRSV-seropositive pigs by real-time reverse transcription-PCR

237 tected in 3 nasal swabs collected from PRRSV-seropositive pigs by real-time RT-PCR and sequencing.

238 we preferentially included more samples from seropositive pigs than from seronegative pigs.

239 Eligible patients were CMV-seropositive, positive for HLA-A*0201, aged 18-75 years,

240 of the TEMRA pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was asso

241 Prospective study involving 144 T. cruzi seropositive pregnant women.

242 jor histocompatibility complex (MHC) in 2782 seropositive RA cases and 4315 controls of Asian descent

243 -trend = 0.004) increased risk of developing seropositive RA compared with those who consumed no suga

244 t soda, is associated with increased risk of seropositive RA in women, independent of other dietary a

245 The mean seropositive rate for all PvTRAgs was 60.3%.

246 newly identified in this study and showed a seropositive rate of >50%.

247 Current dogma suggests risk is greatest in seropositive recipient (R+)/seronegative donor (D-) tran

248 Two of 93 HHV8-seropositive recipients (2.1%) had viral replication in

249 time to onset of prophylaxis failure in CMV-seropositive recipients of allogeneic hematopoietic-cell

250 gans from seropositive donors (D+R-) and 104 seropositive recipients receiving antithymocyte globulin

251 For seropositive recipients unable to take prophylaxis, toxo

252 Rate of reactivation among seropositive recipients was 2.2 and 16%.

253 In patients who were seropositive, reduction in seizure frequency was associa

254 CMV-seropositive responders had significantly higher frequen

255 each HY-Ab was associated with a persistent seropositive response throughout the posttransplant foll

256 table anti-B. pseudomallei antibody, whereas seropositive results among neighborhood contacts was 5%

257 riority trial enrolled patients with active, seropositive rheumatoid arthritis and an inadequate resp

258 CI = 2.05-41.32), as did people who were HIV seropositive (RR = 4.06, 95% CI = 1.42-11.56).

259 e and the highly specific assays, 66 AQP4-Ab seropositive samples were used to establish the sensitiv

260 arasitology are also diagnosed in the field (seropositive [SERO]).

261 and outcomes did not differ significantly in seropositive, seronegative, and statin-associated cases.

262 NT5c1A seropositive sIBM cases had lower total Medical Research

263 Participants with seropositive sIBM took significantly longer to get up an

264 CMV IgG-seronegative (sR(-)) and 86 CMV IgG-seropositive (sR(+)) patients.

265 immunogenicity subgroup of 1944 children had seropositive status for one or more dengue serotypes.

266 ation after cardiac death, hepatitis B and C seropositive status, cigarette use, diabetes, hypertensi

267 formance of a kidney biopsy, cytomegalovirus seropositive status, donation after cardiac death, hepat

268 ng human monoclonal antibody isolated from a seropositive subject.

269 al skin biopsy specimens obtained from HSV-2-seropositive subjects at the time of lesion onset up to

270 nd HLA indicated that the gut microbiomes of seropositive subjects differed from those of autoantibod

271 ression of IL-18Ralpha on NK cells from HCMV seropositive subjects do not fully explain these impaire

272 Bacteroides and Prevotella, respectively, in seropositive subjects with multiple versus one autoantib

273 age, CD4 and gender-matched HIV-infected CMV-seropositive subjects, and among 21 HIV-uninfected contr

274 he salivary microbial composition for 10 HIV-seropositive subjects, before and 6 months after highly

275 antibodies, IgG-94 and IgG-RC, isolated from seropositive subjects.

276 l and cellular immunity commonly seen in CMV seropositive subjects.

277 genome-wide epitopes were compared in HSV-1-seropositive symptomatic individuals (with a history of

278 ignificant proportion of patients may remain seropositive (the "serofast state").

279 immunoglobulin G antibody levels among those seropositive to CMV were also associated with shorter LT

280 Among the controls, 88% were seropositive to H. pylori at baseline.

281 Ninety-five percent of controls were seropositive to H. pylori.

282 tralian states and calculated the proportion seropositive to HPV types 6, 11, 16, and 18.

283 Importantly, individuals seropositive to saliva are 2.1 times more likely to deve

284 Approximately 97% of the population was seropositive to tetanus and diphtheria as defined by a p

285 Twenty-three patients (15.3%) were seropositive to TG6 IgA antibodies as opposed to only 5

286 This study suggests that HIV-seropositive tuberculosis cases may be less infectious t

287 Ninety-three HSV-2-seropositive Ugandan adults collected anogenital swab sp

288 Seropositive patients receiving grafts from seropositive unrelated donors had improved overall survi

289 HBeAg-seropositive vaccine failure HBV-carrier children were a

290 differences in biodiversity were evident in seropositive versus seronegative FDRs.

291 The features of seropositive versus seronegative groups were compared an

292 otent (Neut50 < 0.1 mug/ml) nAbs from a DENV-seropositive volunteer immunized with the tetravalent va

293 a secretion assay (gamma-catch) from healthy seropositive volunteers and expanded in vitro.

294 eview, the 16 initial patients identified as seropositive were the subject of this study.

295 ring of a lung transplant recipient (A2, CMV seropositive) who received a HLA-B27 bilateral lung allo

296 Twenty-five patients who were AQP4-IgG seropositive with an initial STM represented 14% of init

297 We compared (1) HCV-seropositive with HCV-seronegative participants and (2)

298 iated with HPV-16/18 between seronegative vs seropositive women (15-25 years) in the control arm (DNA

299 Among 49 ulcer specimens from 49 HSV-2 seropositive women, by PCR HSV-2 was recovered from 28 (

300 Among 487 infants of 476 seropositive women, congenital T. cruzi infection was de